Adragos Pharma acquires Sanofi’s French manufacturing site

Adragos Pharma, a portfolio company of FSN Capital VI, which is advised by FSN Capital, is strengthening its European manufacturing network through the acquisition of a state-of-the-art plant in Maisons-Alfort near Paris. The seller is Sanofi, the France-based listed pharmaceutical manufacturer. With FSN’s support for the acquisition, Adragos is continuing…